Possible acute rejection associated with the use of the new anti-hepatitis C virus medications

Hepatitis C virus infection is associated with increased morbidity and mortality. It remains a major challenge for management and treatment, especially in patients with renal transplant. The new direct-acting antiviral agents gave big hopes to both clinicians and patients that they can overcome this...

Descripción completa

Detalles Bibliográficos
Autores principales: Karkout, Khaled A., Al Sherif, Saleema, Hussein, Qutaiba, Albawardi, Alia, Boobes, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335885/
https://www.ncbi.nlm.nih.gov/pubmed/30697524
http://dx.doi.org/10.4103/ajm.AJM_171_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335885/
https://www.ncbi.nlm.nih.gov/pubmed/30697524
http://dx.doi.org/10.4103/ajm.AJM_171_17

Ejemplares similares